Anxie-T
On sale on the US market (according to the DSLD)
LifeSeasons Therapeutics, food supplement from the US market
Anxie-T (LifeSeasons Therapeutics), a food supplement au code-barres 853760002155, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- LifeSeasons Therapeutics
- Barcode
- 853760002155
- Form
- Capsule
- One serving
- 2 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Hypromellose, Microcrystalline Cellulose, Rice Bran, Silica
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Magnesium | Mineral | 20 mg |
| L-Theanine | Other substance | 200 mg |
| Andean Cocoa seed extract (Theobroma cacao) | Plant | 100 mg |
| Sensoril (Withania somnifera) | Plant | 100 mg |
| Withanolides | Other substance | 10 mg |
| Gamma-Aminobutyric Acid | Other substance | 100 mg |
| Kava Kava Root Extract | Plant | 100 mg |
| Kavalactones | Other substance | 30 mg |
| Theobromine | Other substance | 50 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Anxie-T
Entered into DSLD on 23 June 2021. Withdrawn from the US market on 13 March 2023 (according to the DSLD).- Active ingredient added : Andean Cocoa extract (100 mg)
- Active ingredient added : Ashwagandha root extract (100 mg)
- Active ingredient added : GABA (100 mg)
- Active ingredient added : Kava Kava extract (100 mg)
- Active ingredient removed : Andean Cocoa seed extract (100 mg)
- Active ingredient removed : Gamma-Aminobutyric Acid (100 mg)
- Active ingredient removed : Kava Kava Root Extract (100 mg)
- Active ingredient removed : Kavalactones (30 mg)
- Active ingredient removed : Sensoril (100 mg)
- Active ingredient removed : Withanolides (10 mg)
Official label: Anxie-T
Entered into DSLD on 24 March 2020. Withdrawn from the US market on 19 March 2021 (according to the DSLD).- Active ingredient added : Ashwagandha root extract (100 mg)
- Active ingredient added : GABA (100 mg)
- Active ingredient added : Kava Kava (100 mg)
- Active ingredient removed : Gamma-Aminobutyric Acid (100 mg)
- Active ingredient removed : Kava Kava Root Extract (100 mg)
- Active ingredient removed : Kavalactones (30 mg)
- Active ingredient removed : Sensoril (100 mg)
- Active ingredient removed : Withanolides (10 mg)
Official label: Anxie-T Stress Support
Entered into DSLD on 25 July 2014. Withdrawn from the US market on 7 October 2019 (according to the DSLD).- Active ingredient added : Ashwagandha extract (100 mg)
- Active ingredient added : Cocoa bean extract (100 mg)
- Active ingredient added : GABA (100 mg)
- Active ingredient added : Kava Kava Piper methysticum (root) extract (100 mg)
- Active ingredient removed : Andean Cocoa seed extract (100 mg)
- Active ingredient removed : Gamma-Aminobutyric Acid (100 mg)
- Active ingredient removed : Kava Kava Root Extract (100 mg)
- Active ingredient removed : Kavalactones (30 mg)
- Active ingredient removed : Sensoril (100 mg)
- Active ingredient removed : Withanolides (10 mg)
- Different quantity per serving : Theobromine: 100 mg in this version; 50 mg on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Sensoril
Read the warning, when it applies and the studies cited
ASHWAGANDHA - WITHANIA SOMNIFERA
Route of administration: Oral
Cautions and warnings
Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).
Sources cited by Health Canada (3)
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).
Sources cited by Health Canada (3)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
- Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : LifeSeasons Therapeutics
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Anxie-T (LifeSeasons Therapeutics): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/853760002155-anxie-t-lifeseasons-therapeutics, updated 23 April 2024.